DNA damage induction by 125I-estrogen

Area of Science:

• Molecular Biology
• Radiation Biology
• Cell Biology

Background:

• Estrogen receptor (ER) signaling plays a crucial role in various cellular processes.
• Targeted radionuclide therapy utilizes radioactive isotopes to deliver cytotoxic radiation to specific cellular components.
• 125I-estrogen (125I-VME2) is a radiolabeled compound designed to target estrogen response elements (EREs) in DNA.

Purpose of the Study:

• To quantify DNA damage, specifically single-strand breaks (ssbs) and double-strand breaks (dsbs), induced by the radioactive decay of 125I-VME2.
• To investigate the dose-response relationship of DNA damage induction by 125I-VME2 in an ER-expressing cell line.
• To compare the DNA damaging potential of 125I-VME2 with other radioiodine compounds like 125IUdR.

Main Methods:

• Utilized a Chinese Hamster Ovary cell line expressing the estrogen receptor (CHO-ER).
• Exposed cells to varying concentrations of 125I-VME2 and accumulated 125I decays at -135°C.
• Assayed DNA damage using alkaline and neutral filter elution techniques to measure ssbs and dsbs, respectively.

Main Results:

• Increasing concentrations of 125I-VME2 led to a detectable increase in both DNA ssbs and dsbs.
• The dose-response curves for DNA ssb and dsb induction by 125I-VME2 exhibited multiphasic patterns.
• DNA ssb induction per 125I-VME2 decay was approximately twice that of dsb induction.
• 125I-VME2 decay induced 4-8 times more DNA dsbs compared to 125IUdR decay.

Conclusions:

• 125I-VME2 effectively induces DNA damage, including both single and double-strand breaks, in ER-expressing cells.
• The study provides quantitative data on the DNA damage potential of 125I-VME2, highlighting its efficiency in inducing double-strand breaks compared to 125IUdR.
• These findings contribute to understanding the radiobiological effects of targeted 125I-labeled compounds for potential therapeutic applications.